Drug · DIN 02270730
PHL-SUMATRIPTAN
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since September 27, 2005; first marketed September 27, 2005.
- Drug Identification Number (DIN)
- 02270730
- Company (DIN owner)
- Pharmel Inc.Montreal, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Sumatriptan N02CC01
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| SUMATRIPTAN (SUMATRIPTAN SUCCINATE) | 100 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- August 24, 2005: NOC 7321Abbreviated New Drug Submission (ANDS) · New manufacturer and product name
Other DINs named PHL-SUMATRIPTAN
- DIN 02270714 · Cancelled Post Market
- DIN 02270722 · Cancelled Post Market